DOI:
10.1055/s-00034916
Nervenheilkunde
LinksClose Window
References
Raison CL, Rutherford RE, Woolwine BJ. et al
A randomized controlled trial of the tumor necrosis factor- alpha antagonist infliximab in treatment resistant depression: role of baseline inflammatory biomarkers.
JAMA Psychiatry 2013;
70 (01) 31-41
We do not assume any responsibility for the contents of the web pages of other providers.